Possibilities of using amiodarone in thyroid pathology-Reference-Cited by-同舟云学术

Possibilities of using amiodarone in thyroid pathology

Published:2024-02-18 Issue:2 Volume: Page:24-38
ISSN:2075-0277
Container-title:Terapevt (General Physician)
language:
Short-container-title:General Physician

Author:

,Shavkuta G. V.^ORCID,Shnyukova T. V.^ORCID, ,Yakovleva N. V.^ORCID, ,Pakhomova V. M., ,Shnyukov V. V., ,Cherkashin A. A.,

Abstract

Amiodarone is currently the most effective drug for life-threatening arrhythmias, however, the instructions for its use indicate thyroid dysfunction (hypothyroidism, hyper thyroidism) as contraindications. Due to the high iodine content, amiodarone can cause damage to the thyroid gland (with the development of hypothyroidism or thyrotoxicosis) in 15–20 % of patients. Before starting amiodarone therapy, it is necessary to assess the pa tient's thyroid status with mandatory determination of thyroid-stimulating hormone. In cases where amiodarone is prescribed for primary or secondary prevention of fatal ventricular arrhythmias or when discontinuation of the drug is impossible for other reasons (any form of arrhythmias that occurs with severe clinical symptoms that cannot be eliminated by other means of antiarrhythmic therapy), compensation for impaired thyroid function is carried out while continuing amiodarone intake.

Publisher

PANORAMA Publishing House

Reference25 articles.

1. 1. Instruktsiia po primeneniiu amiodarona - Vidal [Instructions for use of amiodarone - Vidal]. Available at: https://www.vidal.ru/drugs/amiodarone__8932? ysclid=lo2 nqyugvv812213727 (accessed 12/01/2023). (In Russ.)

2. 2. Instruktsiia po primeneniiu amiodarona - Registr lekarstvennykh sredstv Rossii [Instructions for use of amiodarone - Register of Medicines of Russia]. Available at: https://www.rlsnet.ru/drugs/amiodaron-192? ysclid=lo2 neuvzlq268962978 (accessed 12/01/2023). (In Russ.)

3. 3. Moiseev S. V., Sviridenko N. Iu. Disfunktsiia shchitovidnoi zhelezy, vyzvannaia amiodaronom [Thyroid dysfunction caused by amiodarone]. Klinicheskaia farmakologiia i terapiia [Clinical Pharmacology and Therapy]. 2012; 21 (4). Available at: https:// medi.ru/info/2237/ (accessed 12/01/2023). (In Russ.)

4. 4. Lebedev D. S., Mikhailov E. N., Neminushchii N. M. et al. Zheludochkovye narusheniia ritma. Zheludochkovye takhikardii i vnezapnaia serdechnaia smert. Klinicheskie rekomendatsii [Ventricular rhythm disturbances. Ventricular tachycardia and sudden cardiac death. Clinical guidelines]. 2020. Rossiiskii kardiologicheskii zhurnal [Russian Cardiology Journal]. 2021; 26 (7): 128-189. https://doi.org/10.15829/1560-4071-2021-4600 (In Russ.)

5. 5. Gridneva E. N., Tsoi U. A., Karonova T. L., et al. Proekt federalnykh klinicheskikh rekomendatsii po diagnostike i lecheniiu amiodaron-indutsirovannoi disfunktsii shchitovidnoi zhelezy [Draft federal clinical guidelines for the diagnosis and treatment of amiodarone-induced thyroid dysfunction]. Klinicheskaia i eksperimentalnaia tireoidologiia [Clinical and Experimental Thyroidology]. 2020; 16 (2): 12-21. https:// doi.org/10.14341/ket12693. (In Russ.)